Last reviewed · How we verify
Otitis media due to susceptible Streptococcus pneumoniae
Approved treatments
- Bicillin C-R · Pfizer Inc.
Penicillin G inhibits bacterial cell-wall peptidoglycan biosynthesis, rendering the cell wall osmotically unstable.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Otitis media due to susceptible Streptococcus pneumoniae patent landscape — cliff calendar, originator estates, attackable patents
- Otitis media due to susceptible Streptococcus pneumoniae treatment landscape brief
- Otitis media due to susceptible Streptococcus pneumoniae treatment updates RSS
Frequently asked questions about Otitis media due to susceptible Streptococcus pneumoniae
What drugs treat Otitis media due to susceptible Streptococcus pneumoniae?
Tracked treatments include Bicillin C-R.
What is the treatment for Otitis media due to susceptible Streptococcus pneumoniae?
Standard treatment for Otitis media due to susceptible Streptococcus pneumoniae includes Bicillin C-R. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Otitis media due to susceptible Streptococcus pneumoniae patent cliff · Otitis media due to susceptible Streptococcus pneumoniae CI report
- Treatment: Bicillin C-R · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing